UY30996A1 - COMPOUNDS BASED ON 4, 5, 6, 7-TETRAHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA AND 4,5-DIHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA; COMPOSITIONS CONTAINING THEM, ITS PREPARATION AND APPLICATIONS - Google Patents

COMPOUNDS BASED ON 4, 5, 6, 7-TETRAHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA AND 4,5-DIHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA; COMPOSITIONS CONTAINING THEM, ITS PREPARATION AND APPLICATIONS

Info

Publication number
UY30996A1
UY30996A1 UY30996A UY30996A UY30996A1 UY 30996 A1 UY30996 A1 UY 30996A1 UY 30996 A UY30996 A UY 30996A UY 30996 A UY30996 A UY 30996A UY 30996 A1 UY30996 A1 UY 30996A1
Authority
UY
Uruguay
Prior art keywords
piridin
ona
tetrahydropirrolo
dihydropirrolo
applications
Prior art date
Application number
UY30996A
Other languages
Spanish (es)
Inventor
John Fritiof Ponten
Marika Jenny Susanna Lindhagen
Robert Andrew Judkins
Sara Annelie Helgesson
Leifeng Cheng
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30996A1 publication Critical patent/UY30996A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen ciertos compuestos de 4,5,6,7-tetrahidropirrolo[3,2-c]piridin-4-ona y compuestos de 4, 5 -dihidropirrolo[3,2-c]piridin-4-ona de formula I, procesos para preparar esos compuestos, su uso en el tratamiento de la obesidad, los trastornos psiquiátricos y neurologico, métodos para su uso terapéutico y composiciones farmacéticas que los comprenden.Certain 4,5,6,7-tetrahydropyrrolo [3,2-c] pyridin-4-one compounds and 4,5-dihydropyrrolo [3,2-c] pyridin-4-one compounds of formula I are described, processes to prepare these compounds, their use in the treatment of obesity, psychiatric and neurological disorders, methods for therapeutic use and pharmaceutical compositions that comprise them.

UY30996A 2007-04-03 2008-04-02 COMPOUNDS BASED ON 4, 5, 6, 7-TETRAHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA AND 4,5-DIHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA; COMPOSITIONS CONTAINING THEM, ITS PREPARATION AND APPLICATIONS UY30996A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90978507P 2007-04-03 2007-04-03

Publications (1)

Publication Number Publication Date
UY30996A1 true UY30996A1 (en) 2008-11-28

Family

ID=39592749

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30996A UY30996A1 (en) 2007-04-03 2008-04-02 COMPOUNDS BASED ON 4, 5, 6, 7-TETRAHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA AND 4,5-DIHYDROPIRROLO [3,2-C] PIRIDIN-4-ONA; COMPOSITIONS CONTAINING THEM, ITS PREPARATION AND APPLICATIONS

Country Status (3)

Country Link
AR (1) AR065909A1 (en)
UY (1) UY30996A1 (en)
WO (1) WO2008120000A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60207744T2 (en) * 2001-09-24 2006-08-03 Bayer Pharmaceuticals Corp., West Haven PROCESS FOR THE PREPARATION OF 1,5,6,7-TETRAHYDROPYRROLO [3,2-C] DERIVATIVES FOR THE TREATMENT OF FATIBILITY
AR056560A1 (en) * 2005-10-06 2007-10-10 Astrazeneca Ab PIRROLOPIRIDINONES AS MODULATORS CB1

Also Published As

Publication number Publication date
AR065909A1 (en) 2009-07-08
WO2008120000A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
UY29838A1 (en) SUBSTITUTED DERIVATIVES OF 4,5,6,7-TETRAHIDROPIRROLO (3,2, C) PIRIDIN-4-ONA AND 4,5-TETRAHIDROPIRROLO (3,2, C) PIRIDIN-4-ONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESSES OF PREPARATION AND APPLICATIONS
UY28752A1 (en) THERAPEUTIC AGENTS
CL2008003577A1 (en) Compounds derived from imidazo [1,5-a] pyrido [3,2-e] pyrazine, 2, 6, 7, 9 tetrasubstituted; phosphodiesterase 10 inhibitors; preparation procedure; pharmaceutical composition comprising said compounds; and its use to treat diseases related to the central nervous system, obesity, and metabolic disorders.
CL2008003393A1 (en) Compounds derived from imidazo [1,2-a] pyridine, allosteric modulators of mglur2 receptors; pharmaceutical composition comprising said compounds; and its use in the preparation of medicaments to treat disorders of the central nervous system.
CL2009000447A1 (en) Compounds derived from (1h-pyrrolo {2,3-b} pyridin-5-yl) -sulfonamido-substituted benzamide; preparation procedure; pharmaceutical composition; and its use in the treatment of cancer, through the inhibition of raf.
GT201300137A (en) IMIDAZO DERIVATIVES [1,2-B] PIRIDAZINE AND IMIDAZO [4,5-B] PIRIDINA AS JAK INHIBITORS
ECSP099751A (en) DERIVATIVES OF 9- (PIRAZOL-3-IL) -9H-PURIN-2-AMINA AND 3- (PIRAZOL-3-IL) -3H-IMIDAZO [4,5-B] PIRIDIN-5-AMINA AND ITS USE FOR CANCER TREATMENT
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
DOP2013000105A (en) DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
CO6602133A2 (en) Derivatives of i, idazo (1,2-a) pyrazine and its use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
CO6410279A2 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
UY28376A1 (en) THERAPEUTIC AGENTS
GT200600135A (en) ORTHROMBY CRYSTAL FORM OF ASENAPINE MALEATE AND ITS USE IN THE TREATMENT OF MENTAL DISORDERS
ECSP099662A (en) New Derivatives of 3 - ([1,2,4] triazolo [4,3-a] pyridin-7-yl) benzamide
PE20150883A1 (en) IMIDAZO [1,2-A] PYRIDINE CARBOXAMIDES AMINE SUBSTITUTES AND THEIR USE
CL2007002708A1 (en) COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS.
ECSP066856A (en) NEW COMPOUNDS AS OPIOID RECEIVER MODULATORS
ECSP109903A (en) DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
BR112012013431A2 (en) compound, pharmaceutical composition and its use
UY29796A1 (en) NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
UY28374A1 (en) THERAPEUTIC AGENTS
UY28150A1 (en) THERAPEUTIC AGENTS
ES2340502T3 (en) COMPOUNDS OF 1,4,8-TRIAZAESPIRO (4,5) DECAN-2-ONA SUBSTITUTED FOR THE TREATMENT OF OBESITY.
UY28839A1 (en) THERAPEUTIC AGENTS
CL2012001027A1 (en) Compounds derived from 7- (phenylamine) -5-oxo-1,2,3,5-tetrahydro-imidazo [1,2-a] pyridine, 7- (phenylamine) 5-oxo-2,3-dihydro-5h- thiazolo [3,2-a] pyridine, 7- (phenulamines) -5-oxo-2,3-dihydro-2hoxazolo [3,2-a] pyridine: pharmaceutical composition; Useful in the treatment of diseases, disorders or syndrome associated with mek inhibition.

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120613